Page 2 - Peter Guenter News Today

Positive scientific opinion by EMA would create pathway for arpraziquantel in African endemic countries - News - PharmaTimes

MERCK Kommanditgesellschaft auf Aktien (OTCPK:MKGAF) Q2 2022 Results Conference Call August 04, 2022 08:00 AM ET Company Participants Constantin Fest - Head, IR Belen Garijo - Group, CEO...

Merck KGaA (OTCPK:MKGAF) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - CEO of the Group Marcus...

Merck Announces Appointment of Head of China & International for Healthcare Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow...

Merck invests € 250M in new biotech development centre in Switzerland Merck invests € 250M in new biotech development centre in Switzerland 07 July 2021 | News image credit- businesswire German firm Merck has announced the topping-out ceremony for its new Biotech Development Center in Corsier-sur-Vevey, Switzerland.  This investment of € 250 million, which was announced in January 2020, is intended to help secure the capacities for a cost-efficient and agile provision of clinic...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced changes in its operating model for the Healthcare business sector. Chris Round will become President of EMD Serono leading the North America Healthcare business; Andrew Paterson will assume the position of Chief Marketing Officer; and recruitment is ongoing for the position of Head of China & International. “Our redesigned Healthcare organization creates dedicated leadership for our strategic priorities ...

May 18, 2021 11:39am Germany-based Merck KGaA saw an 8.6% increase in sales in 2020 and looks for even more success with reorganization of its healthcare unit in North America as it tries to spur sales of Mavenclad, Bavencio and Tepmetko. (Fierce Pharma) Belen Garijo took over last month as CEO at Merck KGaA and she’s not wasting time putting her imprint on the company. On Tuesday, the Germany-based company said it had tapped Chris Round as president at its North America healthcare unit, repl...

MERCK KGAA (MKKGY) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. MERCK KGAA (OTC: MKKGY) Operator Good day, and welcome to the Merck Quarter One 2021 Analysts Telco Conference Call. [Operator Instructions] At this time, I would like to turn the conference over to Constantin Fest. Please go ahead.SPONSORED: 10 stocks we like better than Merck KGaA When investing geniuses David and Tom Gardner have a stoc...

Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapant USA - English Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous cell carcinoma of the head and neck, in combination with current standard of care A Phase II trial reported that xevinapant plus chemoradiotherapy reduced risk of death by 51% vs standard...

Debiopharm Grants a Worldwide Exclusive License to Merck for the Development and Commercialization of Xevinapant - Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous cell carcinoma of the head and neck, in combination with current standard of care - A Phase II trial reported that xevinapant plus chemoradiotherapy reduced risk of death by 51% vs standard of care in this patient populati...